The average American woman weighs about 170 pounds and stands about 5 feet, 4 inches tall. But it’s important to remember ...

Seeking Alpha identifies 6 blue-chip stocks with high valuations and limited growth. Learn why Costco, Estée Lauder, and ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Noom data -2 Noom’s GLP-1 companion delivers the following features: Educational resources tailored to GLP-1s, the importance of healthy habits alongside the med, and side-effect management A ...

Another report from Circana found that GLP-1 users traditionally spent more at c-stores than non-users before taking the medications. But in the first year of using GLP-1s, their convenience store ...

The active GLP-1 RA prescription group had a significantly lower risk for 30-day readmission and 180-day postoperative wound dehiscence and postoperative hematoma after matching. HealthDay News ...

In Connecticut, where Medicaid has clamped down on covering GLP-1 medications for obesity, people are looking for alternatives. To make ends meet, some of Reshma Ramachandran’s patients at a ...

One in eight. That's how many people living in the United States have taken some form of a glucagon-like peptide 1, otherwise known as a GLP-1, medication for weight loss and related conditions ...

Lexaria Bioscience (LEXX) it has received the necessary independent ethics board approval required for its contract research organization to begin to implement and execute human pilot study GLP-1 ...

The Study will compare an oral version of liraglutide ... in a future Phase I registered trial. "All three of the GLP-1 and GIP drugs that Lexaria has tested during the last fifteen months ...